Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksR4E.L Regulatory News (R4E)

  • There is currently no data for R4E

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

r4e granted 17% shareholding in digital platform

23 Jan 2014 07:00

RNS Number : 3101Y
Reach4Entertainment Enterprises PLC
23 January 2014
 



23 January 2014

reach4entertainment enterprises plc

('r4e')

r4e granted 17 per cent shareholding innew digital theatre and arts entertainment platform

r4e, the transatlantic media and entertainment marketing company, today announces that it has been granted a 17 per cent shareholding in Stage17 Incorporated ('Stage17') in lieu of support provided by r4e to Stage 17 during its development.

Stage 17 is a rich digital platform that will deliver a range of Broadway and arts related entertainment content. Content will include original and curated video entertainment programming, aimed at a target audience (25-54 year old, primarily female demographic with a demonstrated interest in theatre and the arts), for whom quality, originality, ease of use and sense of community are paramount.

Stage 17, which has been funded and developed by Stoller Family Partners, of which David Stoller, Executive Chairman of r4e is a general partner, will launch in the first half of 2014, although a teaser trailer can be viewed now at http://www.stage17.tv/preview. Its initial focus will be on the North American market. In the short to medium-term, Stage 17's strategic goal is to monetise its offering through a combination of digital advertising, premium membership subscriptions and e-commerce that will be integrated into its digital platform.

r4e will be a preferred supplier of advertising services, marketing and technical support to Stage 17.

As David Stoller is a director of r4e, the Stage 17 transaction is deemed to be a related party transaction under the AIM Rules. As such, the independent directors of the Company, being Richard Ingham and Marcus Yeoman, having consulted with Cantor Fitzgerald Europe, believe that the terms of the Stage 17 transaction are fair and reasonable in so far as the shareholders are concerned.

David Stoller, Executive Chairman, r4e, said:

"Stage 17 has enormous potential to fill the gap in digital theatre and arts entertainment services for what is a vast addressable market. It is estimated that the target demographic community - primarily individuals aged 25-54 with a demonstrated interest in theatre and the arts - for Stage 17 stands at 136 million in the USA, the UK and Australia alone.

"The combination of a very substantial target market and the growing trend of digital advertising spend which, in the USA alone, amounted to $40 billion in 2013 and is forecast to grow to around $100 billion by 2017, presents a very exciting business opportunity.

"This initiative complements the current service offering from r4e's market leading theatre and entertainment branding, design and advertising agencies, presenting an additional and alternative route to market for them to promote their current clients and develop new digital entertainment and media clients generating additional revenues, whilst also offering further exciting opportunities for additional digital platforms and new strategic partnerships."

Ends

Enquiries:

reach4entertainment +44 (0) 20 7968 1655

David Stoller, Executive Chairman

Sarah Hall, Chief Operating Officer

Blythe Weigh Communications +44 (0) 20 7138 3204

Paul Weigh +44 (0) 7989 129658

Eleanor Parry +44 (0) 7551 293620

Cantor Fitzgerald Europe +44 (0) 20 7894 7000

Mark Percy (Corporate Finance)

David Banks / Paul Jewell (Corporate Broking)

 

Allenby Capital +44 (0) 20 3328 5656

 

Katrina Perez/Kelly Gardiner

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRZMGZMMZRGDZZ
Date   Source Headline
20th Sep 20177:00 amRNSHalf-year Report
18th Sep 20177:00 amRNSDirectorate Change
31st Aug 20171:52 pmRNSTrading Update
20th Jul 20177:00 amRNSUpdate on debt facilities with PNC
29th Jun 20175:30 pmRNSPDMR Shareholding
27th Jun 201712:43 pmRNSResult of AGM
23rd Jun 201710:45 amRNSDirectorate Change
26th Apr 20177:00 amRNSFinal Results
3rd Apr 20172:30 pmRNSBanking update
28th Feb 201712:10 pmRNSDirector Declaration
24th Jan 20177:00 amRNSTrading Update and Directorate Changes
4th Jan 201710:46 amRNSHolding(s) in Company
30th Dec 20169:00 amRNSTotal Voting Rights
29th Dec 20164:00 pmRNSHolding(s) in Company
22nd Dec 20167:00 amRNSBanking update
21st Dec 20165:18 pmRNSIssue of equity, PDMR dealing and TVR
7th Dec 20165:21 pmRNSHolding(s) in Company
30th Nov 20165:30 pmRNSTotal Voting Rights
18th Nov 20165:55 pmRNSHolding(s) in Company
15th Nov 20169:45 amRNSHolding(s) in Company
7th Nov 201611:15 amRNSHolding(s) in Company
1st Nov 201611:11 amRNSHolding(s) in Company
26th Oct 20165:38 pmRNSCompletion of placing and director/PDMR dealing
26th Oct 201612:12 pmRNSProposed placing
14th Sep 20162:00 pmRNSNew German Subsidiary
12th Sep 20167:00 amRNSHalf-year Report
26th Jul 20162:06 pmRNSHolding(s) in Company
29th Jun 20161:30 pmRNSResult of AGM
29th Jun 20167:00 amRNSAGM Statement
22nd Jun 20169:30 amRNSDirector Disclosure Update
25th May 20167:00 amRNSFinal Results
19th May 20163:40 pmRNSHolding(s) in Company
18th May 20169:52 amRNSHolding(s) in Company
11th May 201610:15 amRNSHolding(s) in Company
5th May 201610:55 amRNSHolding(s) in Company
3rd May 20167:00 amRNSAppointment of Director
29th Apr 20167:00 amRNSNotice of Results, Q1 update, director holding
27th Apr 20167:00 amRNSAIM Disclosure Update
8th Apr 20169:27 amRNSHolding(s) in Company
5th Apr 201612:15 pmRNSHolding(s) in Company
31st Mar 20165:30 pmRNSTotal Voting Rights
22nd Mar 20167:00 amRNSCompletion of Acquisition, Issue of Equity, TVR
4th Mar 20165:23 pmRNSGrant of Options
4th Mar 20169:07 amRNSNew CEO of Dewynters and Acquisition
1st Mar 20167:00 amRNSTotal Voting Rights
29th Feb 20167:00 amRNSTrading Statement
15th Feb 20163:10 pmRNSDirectorate Change
10th Feb 20169:37 amRNSHolding(s) in Company
8th Feb 20164:15 pmRNSIssue of Equity and Total Voting Rights
22nd Jan 201610:07 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.